New Treatment in Australia: A New Breakthrough for Reducing Body Weight?
Australia is eagerly anticipating the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor agonist , representing a exciting advance in obesity treatment . Early clinical trials have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. W